FDA grants breakthrough status to new Hodgkin's lymphoma therapy
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Adcetris (brentuximab vedotin) in combination with chemotherapy for the frontline treatment of patients with advanced classical Hodgkin's lymphoma. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

Transgene and Randox to develop oncolytic treatment for solid tumours
Transgene has a partnered with in-vitro diagnostics company Randox to combine their technologies and develop multifunctional oncolytic immunotherapies. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

US FDA grants priority review status to Allergan ’s sNDA for Avycaz
The US Food and Drug Administration (FDA) has granted priority review status for Allergan ’s supplemental New Drug Application (sNDA) for Avycaz (ceftazidime and avibactam) to treat hospital-acquired bacterial pneumonia / ventilator-associated bacteri… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

Vivapur mcg
Liquid dosage forms are a common and popular approach to overcoming the many obstacles of administering medicines to children, the elderly, and animals. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

TPF Control Expands Services to Offer DataTrace Calibration
Mesa Labs has announced the expansion of services of its European calibration center TPF Control. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

ElectraSyn: A Potentiostat, Analytical Device, and Stir Plate
In a unique endeavor, IKA's owner Ren é Stiegelmann has partnered with Professor Phil S. Baran of Scripps Research Institute in La Jolia, California. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

Aspects of Quality by Design in HPLC Method Development
This is a presentation by Molnar, which explores the aspects of Quality by Design in HPLC method development. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 2, 2017 Category: Pharmaceuticals Source Type: news

Mylan launches generic version of Gleevec tablets in US
Mylan has launched the generic version of Novartis's Gleevec tablets, Imatinib Mesylate, in 100mg and 400mg versions in the US.   (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 1, 2017 Category: Pharmaceuticals Source Type: news

Central Institute for Translational Cancer Research (TranslaTUM), Technical University of Munich
The Central Institute for Translational Cancer Research (TranslaTUM) is a new interdisciplinary research building officially inaugurated at the Technical University of Munich in September 2017. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 1, 2017 Category: Pharmaceuticals Source Type: news

NICE recommends use of Janssen ’s Imbruvica for Waldenstr ö m ’s macroglobulinaemia
The National Institute for Health and Care Excellence (NICE) in the UK has recommended the use of Janssen Pharmaceutical ’s Imbruvica (ibrutinib) on the Cancer Drugs Fund (CDF) to treat adults with a type of   non-Hodgkin lymphoma called Waldenstr ö m ’s m… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 1, 2017 Category: Pharmaceuticals Source Type: news

Notrox Research-Bioequivalence Studies and CRO Services for Drug Development
Notrox Research is a contract research organisation (CRO) that conducts clinical research trials for pharmaceutical companies. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news

GSK ’s Benlysta receives Japanese MHLW approval for systemic lupus erythematosus
GSK ’s human monoclonal antibody Benlysta (belimumab) has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to treat adult patients with systemic lupus erythematosus (SLE), a chronic, incurable, autoimmune disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news

EC grants marketing authorisation for Sanofi and Regeneron ’s Dupixent for AD
The European Commission (EC) has granted marketing authorisation for Sanofi and Regeneron Pharmaceuticals ’ Dupixent (dupilumab) to treat adults with moderate to severe atopic dermatitis (AD), a form of eczema. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news

Deals this week: Mithra, Hainan Haiyao, TherapeuticsMD
Belgium-based pharmaceutical company Mithra has signed a licensing agreement with Brazilian biopharmaceutical company Libbs to commercialise its Estelle oral contraceptive (COC) product in Brazil. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news

M & As this week: Zhejiang Hisoar Pharmaceutical, tella
Chinese pharmaceutical company Zhejiang Hisoar Pharmaceutical plans to divest 16.1% stake in a biotechnology company. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 28, 2017 Category: Pharmaceuticals Source Type: news